Animal models for ebolavirus countermeasures discovery: what defines a useful model?
Authors:
- 25 May 2015
- journal article
- review article
- Published by Informa Healthcare in Expert Opinion on Drug Discovery
- Vol. 10 (7) , 685-702
Abstract
Ebolaviruses are highly pathogenic filoviruses, which cause disease in humans and nonhuman primates (NHP) in Africa. The Zaire ebolavirus outbreak in 2014, which continues to greatly affect Western Africa and other countries to which the hemorrhagic fever was exported due to travel of unsymptomatic yet infected individuals, was complicated by the lack of available licensed vaccines or therapeutics to combat infection. After almost a year of research at an increased pace to find and test vaccines and therapeutics, there is now a deeper understanding of the available disease models for ebolavirus infection. Demonstration of vaccine or therapeutic efficacy in NHP models of ebolavirus infection is crucial to the development and eventual licensure of ebolavirus medical countermeasures, so that safe and effective countermeasures can be accelerated into human clinical trials. The authors describe ebolavirus hemorrhagic fever (EHF) disease in various animal species: mice, guinea pigs, hamsters, pigs and NHP, to include baboons, marmosets, rhesus and cynomolgus macaques, as well as African green monkeys. Because the NHP models are supremely useful for therapeutics and vaccine testing, emphasis is placed on comparison of these models, and their use as gold-standard models of EHF. Animal models of EHF varying from rodents to NHP species are currently under evaluation for their reproducibility and utility for modeling infection in humans. Complete development and licensure of therapeutic agents and vaccines will require demonstration that mechanisms conferring protection in NHP models of infection are predictive of protective responses in humans, for a given countermeasure.Keywords
This publication has 120 references indexed in Scilit:
- Immunopathogenesis of Severe Acute Respiratory Disease in Zaire ebolavirus-Infected PigsPLOS ONE, 2013
- Transmission of Ebola virus from pigs to non-human primatesScientific Reports, 2012
- Delayed treatment of Ebola virus infection with plant-derived monoclonal antibodies provides protection in rhesus macaquesProceedings of the National Academy of Sciences, 2012
- Generation times in wild chimpanzees and gorillas suggest earlier divergence times in great ape and human evolutionProceedings of the National Academy of Sciences, 2012
- Evaluation of Perceived Threat Differences Posed by Filovirus VariantsBiosecurity and Bioterrorism: Biodefense Strategy, Practice, and Science, 2011
- Advances in Virus-Like Particle Vaccines for FilovirusesThe Journal of Infectious Diseases, 2011
- Host Response Dynamics Following Lethal Infection of Rhesus Macaques With Zaire ebolavirusThe Journal of Infectious Diseases, 2011
- A small nonhuman primate model for filovirus-induced diseaseVirology, 2011
- Validation of assays to monitor immune responses in the Syrian golden hamster (Mesocricetus auratus)Journal of Immunological Methods, 2011
- T Cell-Specific siRNA Delivery Suppresses HIV-1 Infection in Humanized MiceCell, 2008